Cite

HARVARD Citation

    Martini, D. et al. (2021). Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors. Oncologist. pp. e1742-e1750. [Online]. 
  
Back to record